The groundbreaking approach of the medication represents a major breakthrough in the care of the condition. Different to existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide078133.onzeblog.com/42202915/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment